Priovant Gets FDA Fast Track For Brepocitinib In NIU
23 Sep 2024 //
PR NEWSWIRE
Roivant Provides Update on Graves’ Disease Development Program
09 Sep 2024 //
GLOBENEWSWIRE
Roivant`s anti-inflammatory drug shows promise in mid-stage study
03 Apr 2024 //
REUTERS
Roivant Sciences` lupus drug fails to reduce symptoms in mid-stage study
28 Nov 2023 //
REUTERS
Roivant Sciences Reports Financial Results for the First Quarter
15 Aug 2022 //
GLOBENEWSWIRE